Skip to content

Neurology for the Non-Neurologist

Friday, March 28, 2025

Hershey Country Club

1000 E. Derry Road
Hershey, PA 17033

More about the location

Select this button to navigate the sections of this page

Conference ID

D7061

Purpose/Overview

Participants are saying
“The program was very informative and I gained new knowledge.”
2023 Participant

Neurological disorders are among the most common conditions seen in clinical practice, and uncomplicated cases are managed well by primary care providers. However, neurology is a rapidly changing field, with new treatments constantly evolving. The major goal of this annual conference is to provide a refresher and update for primary care providers on diagnostic and treatment approaches to common conditions, including neuropathy, epilepsy, muscle diseases, dementia, multiple sclerosis, movement disorders, stroke and others.

2025 Theme

“What You Can Do” – Focusing on Evidence-Based Approaches to Support Patients While Awaiting Neurological Consultation and Complement Medical Therapies

Audience

Internal and family medicine physicians, nurse practitioners, physician assistants, as well as those practitioners in neurology and other healthcare professionals, may benefit from attending this activity.

Agenda

  • 8 a.m. | Registration/Continental Breakfast
  • 8:20 a.m. | Opening Remarks
  • 8:30 a.m. | First Seizure: Guidelines, Evaluation and Treatment
    Tiffany Fisher, MD, PhD

    Objectives
    • Review the ILAE guidelines.
    • Describe factors that contribute to the decision to treat.
    • Examine special populations.
    • Analyze antiseizure drugs and side effects.
  • 9:10 a.m. | Making You a “D” Student: The Basics of Vitamin D and the Risk of Multiple Sclerosis and Other Autoimmune Syndromes
    Gary Thomas, MBA, MD

    Objectives
    • Discuss the role of vitamin D in our body and our immune system.
    • Review how vitamin D levels can impact our risk for developing chronic illness including MS.
    • Describe how vitamin D levels impact the disease course and severity of disease in MS and other autoimmune conditions.
    • Identify a strategy for proactively managing vitamin D for better patient outcomes.
  • 9:50 a.m. | Break/Visit Exhibitors
  • 10:05 a.m. | Neuromuscular Ultrasound: A New Technique in the Evaluation of Neuromuscular Disorders – An Overview of Its Implications, with a Focus on Its Role in Entrapment Neuropathy
    Mansoureh Mamarabadi, MD

    Objectives
    • Explore the diagnostic benefits of neuromuscular ultrasound in assessing neuromuscular disorders.
    • Examine the role of neuromuscular ultrasound in early detection and management of entrapment neuropathies, highlighting its advantages over traditional methods.
  • 10:45 a.m. | EMG Basics: What It Tells You and When Not to Order vs. How to Work Up Numbness
    James Grogan, MD, MS

    Objectives
    • Recognize limitations of what NCS and EMG can and cannot measure.
    • Apply concepts of NCS/EMG and neuroanatomy to identify quality of studies.
    • Identify common errors or artifacts in NCS and EMG studies.
  • 11:25 a.m. | Lunch/Visit Exhibitors
  • 12:30 p.m. | “Non-Medication” Options for Treatment of Headaches and Cephalgia
    William Jens, DO

    Objectives
    • Discuss non medication options for headaches including nutraceuticals and devices.
    • Discuss referral options for injections or therapy for patients opting to avoid medications.
  • 1:10 p.m. | Beyond the Tremor: Early Recognition of Parkinson’s Disease – Motor and Non-Motor
    Joseph Seemiller, MD

    Objectives
    • Differentiate early subtle manifestations of Parkinson’s disease from essential tremor and other parkinsonian syndromes.
    • Identify the initial steps of treatment for parkinsonism until neurology evaluation: drug therapy and non-drug therapy.
  • 1:50 p.m. | Break/Visit Exhibitors
  • 2:05 p.m. | Current Management of Mild Cognitive Impairment and Dementia
    Krishnankutty “Krish” Sathian, MBBS, PhD, FANA, FAAN, FASNR, FRCP (London)

    Objectives
    • Explain the syndromes of mild cognitive impairment and dementia.
    • Describe the pathophysiology of Alzheimer’s disease and the corresponding diagnostic tests.
    • List the indications, benefits, and risks of anti-amyloid agents and describe how they are used.
  • 2:45 p.m. | Updates in Primary and Secondary Ischemic Stroke Prevention
    Kelsey Coleman, DO

    Objectives
    • Define primary and secondary stroke prevention and understand the differences in approaches for each.
    • Review current evidence-based strategies for primary and secondary prevention of ischemic stroke, including lifestyle modification and medical interventions.
    • Examine the role of medications including anti-thrombotic, lipid-lowering therapy, and diabetes medications in both primary and secondary stroke prevention.
    • Develop skills for assessing stroke risk and creating individualized prevention plans for patients in primary care settings.
  • 3:25 p.m. | Closing Remarks/Adjournment

Course Directors

Badge that says Best Hospitals U.S. News and World Report 2024-2025, Neurology & Neurosurgery

James Grogan, MD, MS
Assistant Professor, Department of Neurology
Division of Neuromuscular Medicine
Penn State Neuroscience Institute
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

William Jens, DO
Assistant Professor, Department of Neurology
Division of General Neurology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Presenters

Participants are saying
“Excellent presentations with informative materials for professional and personal use.”
2023 Participant

Kelsey Coleman, DO
Assistant Professor and Associate Vice Chair for Quality, Department of Neurology
Division of Stroke/Vascular
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Tiffany Fisher, MD, PhD
Assistant Professor and Associate Vice Chair for Diversity, Equity and Inclusion, Department of Neurology
Chief, Division of Epilepsy
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

James Grogan, MD, MS
Assistant Professor, Department of Neurology
Division of Neuromuscular Medicine
Penn State Neuroscience Institute
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

William Jens, DO
Assistant Professor, Department of Neurology
Division of General Neurology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Mansoureh Mamarabadi, MD
Assistant Professor, Department of Neurology
Division of Neuromuscular Medicine
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Krishnankutty “Krish” Sathian, MBBS, PhD, FANA, FAAN, FASNR, FRCP (London)
Professor and Chair, Department of Neurology
Professor, Department of Neuroscience and Experimental Therapeutics
Professor, Psychology
Director, Penn State Neuroscience Institute
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine
Penn State College of Liberal Arts

Joseph Seemiller, MD
Assistant Professor, Department of Neurology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Gary Thomas, MBA, MD
Associate Professor, Department of Neurology
Chief, Division of Neuroimmunology
Penn State Health Milton S. Hershey Medical Center
Penn State College of Medicine

Credit

AMA

Penn State College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Penn State College of Medicine designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Using AMA Credit

Nurses will receive a certificate from Penn State College of Medicine verifying their participation in up to 5.25 hours of approved continuing medical education. Continuing education activities which are approved by accredited institutions of higher education and that are relevant to patient care or professional nursing meet the requirements of mandatory continuing education for registered nurses in Pennsylvania, as required by the Pennsylvania State Board of Nursing. The Board of Nursing recommends that nurses retain their certificates for a period of at least five years. Additional information is available through the State Board of Nursing.

Occupational Therapy

Penn State is an approved provider as defined by Title 49, Chapter 42 Pa Code 42.54 (c)(6). Occupational Therapists licensed by the state of Pennsylvania can earn clock hours of continuing education for completing this course.

Social Work

Penn State is an approved provider as defined by Pa. Code Sections 47.36(a)(3), 48.36(a)(3), and b49.36 (a)(3). Social workers, marriage and family therapists and professional counselors licensed by the state of Pennsylvania can earn up to 5.25 clock hours of continuing education for completing this course.

Fees

The fee is $100 per person and includes the cost of instruction, all listed meals and online handout materials.

Payment is required at the time of registration. If you have any questions or concerns, please email us at ContinuingEd@pennstatehealth.psu.edu.

Registrations received after Thursday, March 27, 2025 will incur a $25 late fee.

Cancellations received after Friday, March 21, 2025, will be assessed a $25 processing fee.

No refunds will be made for cancellations received after Tuesday, March 25, 2025.

Accommodation and Room Blcok

Accommodations are the responsibility of the program participant. A list of lodging in the Hershey area is available online.

Local Attractions

Join us in Hershey

Hershey is conveniently located in central Pennsylvania, just 90 minutes from Baltimore and Philadelphia, two hours from Washington, D.C., and three hours from New York City.

Evaluation

A completed evaluation is required in order to receive a certificate for attending this activity. Please complete and submit the evaluation within the specified time frame.

Cancellations

The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances. If a program is canceled or postponed, the University will refund any program registration fees paid but cannot be held responsible for any related costs, charges or expenses, including cancellation/change charges assessed by airlines or travel agencies.

Program registrants who are experiencing illness or have been exposed to anyone who is ill should contact the Continuing Education office before attending any in-person activities.

Changes

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

COVID-19

On-campus educational activities provided by Penn State College of Medicine Continuing Education are required to follow healthcare facility guidelines. Off-campus events provided by Penn State College of Medicine Continuing Education follow the COVID-19 requirements of that venue. We ask that all participants respect that some attendees may still choose to wear masks for activities. Check the venue website for the latest requirements and recommendations. Please do not attend this activity if you have symptoms or have been exposed to someone with COVID-19. By attending the activity, you attest that you do not have any symptoms suggestive of COVID-19, which may include fever, cough, shortness of breath, sore throat, loss of taste, loss of smell or any other sign of illness.

Access (ADA)

Penn State encourages people with disabilities to participate in its programs and activities. Participants who anticipate needing any type of special accommodation or who have questions about the physical access provided should contact the Continuing Education office at least one week in advance of participation or visit.

Disclosure and Conflict of Interest (COI and Educational Balance)

It is Penn State policy to ensure balance, independence, objectivity and scientific rigor in all educational activities. Penn State has a process in place to mitigate any relevant financial relationships with commercial companies disclosed by faculty, course directors and planning committee members. Complete disclosure information will be provided to participants at the beginning of the activity.

University Nondiscrimination Policy

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission and employment without regard to personal characteristics not related to ability, performance or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment or retaliation against faculty, staff or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; 814-863-0471 (TTY). US M.Ed. D7061

Jump to ...